Navigating the Frontier of Hematologic Malignancy Therapies. Series of 5 Modules 3.00 CE Credit(s) LEARN MORE
Exploiting BCMA in the Treatment of Multiple Myeloma: How Could Bispecific Antibodies and T-Cell Engagement Impact Relapsed/Refractory Disease? Proceedings from a Clinical Olympics℠ 1.0 CE Credit(s) LEARN MORE